Showing results (311-320 of 345) with videos related to
Sort By:
Pageof 35
Cancer Immunity|March 29, 2007
Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patientsKhoon Lin Ling, Sarah E Pratap, Gaynor J Bates, et al.Breast (Edinburgh, Scotland)|January 5, 2019
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytesNancy Tray, Jessica Taff, Baljit Singh, et al.Nature Medicine|July 15, 2003
Cadmium mimics the in vivo effects of estrogen in the uterus and mammary glandMichael D Johnson, Nicholas Kenney, Adriana Stoica, et al.Plos One|October 25, 2013
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancerXinyu Wu, Yirong Li, Jinhua Wang, et al.Breast Cancer Research and Treatment|June 4, 2017
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Jeffrey I Campbell, Christina Yau, Polina Krass, et al.Journal of Cellular and Molecular Medicine|October 21, 2009
Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasionYi Peng, Yirong Li, Lan Lin Gellert, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 8, 2025
Results of the international audit for faecal incontinence on behalf of the European Society of Coloproctology (ESCP) collaborating groupAudrius Dulskas, Dovile Cerkauskaite, Alaa El-Hussuna, et al.The British Journal of Surgery|November 6, 2022
Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemicCarmel Conefrey, Cynthia Ochieng, Christin Hoffman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Development and validation of a method for using breast core needle biopsies for gene expression microarray analysesMatthew Ellis, Natalie Davis, Andrew Coop, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)William M Sikov, Donald A Berry, Charles M Perou, et al.Pageof 35